Considerations for Implementing Cabotegravir (Apretude) as PrEP for HIV Infection

Am Fam Physician. 2024 Apr;109(4):296.
No abstract available

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Diketopiperazines*
  • HIV Infections* / prevention & control
  • HIV Integrase Inhibitors / administration & dosage
  • HIV Integrase Inhibitors / therapeutic use
  • Humans
  • Pre-Exposure Prophylaxis / methods
  • Pyridines / therapeutic use
  • Pyridones* / therapeutic use

Substances

  • Pyridones
  • cabotegravir
  • Pyridines
  • HIV Integrase Inhibitors
  • Anti-HIV Agents
  • Diketopiperazines